Abstract: Voltage-dependent anion channel 1 (VDAC1), which is located in the outer mitochondrial membrane, plays important roles in various cellular processes. For example, oligomerization of VDAC1 is involved in the release of cytochrome c to the cytoplasm, leading to apoptosis. However, it is unknown how VDAC1 oligomerization occurs in the membrane. In the present study, we determined high-resolution crystal structures of oligomeric human VDAC1 (hVDAC1) prepared by using an Escherichia coli cell-free protein synthesis system, which avoided the need for denaturation and refolding of the protein. Broad-range screening using a bicelle crystallization method produced crystals in space groups C222 and P22 1 2 1 , which diffracted to a resolution of 3.10 and 3.15 Å , respectively. Each crystal contained two hVDAC1 protomers in the asymmetric unit. Dimer within the asymmetrical unit of the crystal in space group C222 were oriented parallel, whereas those of the crystal in space group P22 1 2 1 were oriented anti-parallel. From a model of the crystal in space group C222, which we constructed by using crystal symmetry operators, a heptameric structure with eight patterns of interaction between protomers, including hydrophobic interactions with bstrands, hydrophilic interactions with loop regions, and protein-lipid interactions, was observed. It
Introduction
Mitochondrial voltage-dependent anion channels (VDACs) are large pore-forming proteins that mediate the exchange of chemical energy, such as ATP, ADP, NADH, succinate, malate, and ions, between the cytosol and the mitochondrial intermembrane space. 1, 2 In mammals, there are three isoforms of VDAC (VDAC1, VDAC2, and VDAC3), which are involved in many physiological and pathophysiological events including energy metabolism, 1, 3 overexpressed in many kinds of cancer cells, [3] [4] [5] and cell death. [6] [7] [8] [9] Recently, the three-dimensional structures of recombinant human VDAC1 (hVDAC1), murine VDAC1 (mVDAC1), and zebrafish VDAC2 were solved by using NMR spectroscopy [10] [11] [12] and X-ray crystallography. 13, 14 These studies revealed that the structures of VDAC1 and VDAC2 have a b-barrel architecture, comprising 19 b-strands with a horizontally oriented a-helix N-terminus positioned midway within the pore. VDAC1 is the most abundant, and therefore well studied, of the three VDAC isoforms. Several reports have suggested its involvement in mitochondriamediated apoptosis. [15] [16] [17] In mitochondria-mediated apoptosis, VDAC1 likely forms oligomers that mediate the passage of cytochrome c to the cytoplasm. 15, [17] [18] [19] Even though three-dimensional structures of VDAC1 and VDAC2 have been determined, little is known about their oligomerization. Since the previously reported crystal structures contained only one protomer in the asymmetric unit, the protomer alignment deduced using symmetry operators revealed only dimers that were oriented parallel or anti-parallel. 11, 13, 14, 20 The existence of VDAC as oligomers has been demonstrated by using various approaches including atomic force microscopy, 21, 22 electron microscopy, 23, 24 and site-directed mutagenesis. 25 In addition, previous research has strongly suggested a dimeric organization of hVDAC1 by analysis of crystal packing, 11, 20 chemical crosslinking, 25 and fluorescence spectroscopic data. 26 It is likely that there are multiple modes of VDAC oligomerization and multiple types of interaction between VDAC protomers. However, despite the availability of high-resolution structures of VDACs, the oligomer state of VDAC1 in the outer mitochondrial membrane remains unknown.
In the present study, we determined novel crystal structures of hVDAC1 protein with resolutions of 3.10 Å and 3.15 Å . These crystal structures revealed a heptameric structure with protomers parallel to one another and a novel oligomeric interaction state. Analysis of hVDAC1 crystal packing in a lipid environment suggested that oligomerization is accomplished via protein-protein and protein-lipid interactions. We also discuss the relative arrangement of the hVDAC1 oligomer interfaces.
Results and Discussion

Preparation of human VDAC1 protein
We produced hVDAC1 by using an Escherichia coli cell-free protein synthesis system in the present study. The crystal structures of mVDAC1 at 2.3 Å (PDB ID: 3EMN), hVDAC1 at 4.1 Å (PDB ID: 2JK4), and zebrafish VDAC2 at 2.8 Å (PDB ID: 4BUN), and the NMR structure of hVDAC1 (PDB ID: 2K4T), were reported previously. 10, 11, 13, 14 These VDAC proteins were produced within E. coli cells as inclusion bodies and needed denaturation and refolding before purification and crystallization. 27 These additional steps required time, effort, and large amounts of reagents, and might cause misfolding of the protein, in part or in whole. However, the E. coli cell-free system produced hVDAC1 without the formation of inclusion bodies or aggregations [ Fig. 1(A) ]. After purification, approximately 1.0 mg of hVDAC1 was obtained from 9 mL of reaction mixture. Due to the potential for large-scale production of folded VDAC protein, this cell-free system will be useful for producing VDAC for future activity measurements, structural analyses, and mutation studies.
To examine the gating activity of the prepared hVDAC1, purified hVDAC1 was incorporated into planar lipid bilayers and current traces under applied voltage were recorded [ Fig. 1(B) ]. Under constant voltage, typical single-channel gating at both positive and negative potentials was observed; the hVDAC1 channel gated under voltages greater than 130 mV or less than 230 mV. The open-state conductance of hVDAC1 was calculated as 1.27 nS (in 250 mM KCl), indicating that the channel function of the hVDAC1 produced with the E. coli cell-free synthesis system was comparable to that of refolded hVDAC1. 28 
Overall structure
The two different crystallization buffer conditions used produced crystals with a thin, square or rod morphology in 5 to 10 days. These two types of crystals had resolutions of 3.1 to 3.2 Å . One type of crystal is in space group P22 1 2 1 and has two protomers per asymmetric unit. The other was a lattice in space group C222 and has two protomers per asymmetric unit. Both crystals were grown in lipidic bicelles. Data collection and refinement statistics are presented in Table I .
The two types of hVDAC1 protomer are composed of an N-terminal helix and a b-barrel comprising 19 b-strands (Fig. 2) . b-strands 1 to 18 are arranged anti-parallel, and b-strand 19 is arranged parallel to b-strand 1, resulting in sealing of the barrel. The N-terminus forms a distorted a-helix in the b-barrel pore, causing partial narrowing of the substrate pathway. The maximal height and width of the b-barrel is 35 and 48 Å , respectively. A structural comparison of the P22 1 2 1 and C222 protomers revealed a root-mean-square deviation (RMSD) under 0.9 Å .
Within each asymmetrical unit, several water molecules and acyl chains from the lipid molecules were clearly observed, and spermidine, which was included in the crystallization buffer, was detected in the space between the a-helix and b-sheet 12-13 of the C222 protomer structure (Fig. 3) .
The RMSD between the crystal structure of our crystal in space group C222 and those of hVDAC1 (PDB ID: 2JK4), 11 mVDAC1 (PDB ID: 3EMN), 13 Fig. 4(A) ]. Although the structures of the a-helix and b-sheets of hVDAC1 are similar to those of mVDAC1 or zebrafish VDAC2, the large loop regions (the loops between bstrands 1 and 2, 6 and 7, and 18 and 19) adopt rather different structures. Moreover, despite having the same amino acid sequence, the a-helix structure and large loops of hVDAC1 (PDB ID: 2JK4) are different from those in our models [ Fig. 4(B) ]. It is possible that these differences in the structures of hVDAC1 are due to the resolutions achieved.
Human VDAC1 oligomeric organization
The oligomer configuration of VDACs is likely correlated with their physiological function. Several studies have shown that VDACs can assume many oligomer states, including monomers, dimers, trimers, tetramers, hexamers, and even higher-level oligomers, depending on the cellular environment. 22 This arrangement has recently been shown to be more dynamic and more influenced by the lipidic environment than previously thought. 26 Previously, crystal structures using crystallographic symmetry operators were reported with parallel or antiparallel dimer structures. 11, 13, 20 In the present study, the orientation of the protomers in the dimer of the crystals in space group P22 1 2 1 or C222 was anti-parallel or parallel, respectively (Fig. 2) . In an analysis of the interface interactions of the crystal in space group C222, a heptameric structure with eight different patterns of interaction between protomers was observed (Table II , Fig. 5 ). These interface interaction patterns were observed in the hVDAC1 heptameric structure model, which was constructed using crystal symmetry operators (Fig. 5 ). This heptameric structure comprises one hVDAC1 protomer surrounded by six external protomers. The parallel dimer conformation in the asymmetrical unit of the crystal in space plane C222 is depicted as chain A and chain B (same interface interaction as chain A2-B2 and chain A4-B4) in Figures 2(C) and 5. The interface between chains A and B is formed from strands b12 (Phe178), b13 (Phe190 and Gln196), b14 (Leu208 and Trp210), b15 (Phe219), the loop region of strands b14-15 (Asn214 and Ser215), and four acyl chains from lipid molecules [ Table II , Fig. 5(A) ]. The closest distance from the side chain of Asn214 in chain A to the main chain carbonyl group of Ser215 in chain B is 3.4 Å . This is the only protein-protein interaction at this interface; however, there are CH/p interactions between the four acyl chains and the aromatic amino acids Trp210 and Phe219 in chain A and Phe178, Phe190, Trp210, and Phe219 in chain B [ Fig. 5(A) ]. This suggests that hydrophobic proteinlipid molecule interactions are important for hVDAC1 oligomerization, and that hVDAC1 oligomerization is influenced by the lipid environment. Therefore, the lipid composition of the outer mitochondrial membrane may play an important role in regulating the oligomeric state of VDAC.
By using crystallographic symmetry operators, we identified a parallel interface between chain B3 and B4, which is consistent with that suggested for hVDAC1 (PDB ID: 2JK4) and zebrafish VDAC2 (PDB ID: 4BUM), with a buried surface area of 207.6 Å 2 [ Fig. 5 (G), Table II) . 11, 14 The interacting surface is formed from hydrophobic amino acids in strands b1 (Ile27, Leu29), b17 (Leu251), b18 (Ile255, Leu257), b19 (Leu277, Leu279), and the loop region of strands b2-3 (Thr52), which is consistent with the dimer interfaces previously determined for hVDAC1 (PDB ID: 2JK4) and zebrafish VDAC2 (PDB ID: 4BUM). Therefore, this type of interaction is likely conserved universally in VDAC oligomerization. Schredelseker et al. have reported similar interactions at the interface of zebrafish VDAC2 by using double electron-electron resonance methods and Cys mutation-based cross-linking studies.
14 Of the eight patterns of interaction, the largest surface has a buried surface area of 946.7 Å 2 and is formed from buried hydrophobic residues in strands b1 (Ile27 and Leu29), b7 (Tyr118), b8 (Ile123 and Leu125), b9 (Leu142 and Leu144), b17 (Leu251), b17 (Leu257), and b19 (Leu277, Leu279, and Phe281) in chain A-B2 or chain A2-B [Table II , Fig.  5(D) ]. This type of interaction has not previously been reported. The large buried surface area, hydrophobicity at the interface, and large contactable surface comprising strands b1, b17, b18, and b19 as described between chain B3 and B4 indicate that this type of interface exists physiologically in the outer mitochondrial membrane. The interface between chains A and B3 is formed through Glu73-Glu73 (distance between side chains, 3.4 Å ) and Phe103-Asn79 (distance between side chains, 3.1 Å ) interactions. Despite the charged side chain, Glu73 is buried in a hydrophobic environment in the middle of the membrane bilayer [ Fig. 5(E) ]. 29 A previous mVDAC1 structural study showed that Ca 21 and Mg 21 bind to Glu73, 13 and it has been suggested that Ca 21 is involved in the regulation of the function of VDAC in the process of mitochondria-dependent cell death. 30 Mutagenesis and functional analyses have suggested that this Glu73 residue is involved in Ca 21 binding. 30 The oligomeric assembly of VDAC1 has been shown to be involved in the induction of apoptosis 7, 15, [17] [18] [19] 31, 32 in which Glu73 residues interact to promote VDAC1 oligomerization. The Glu73-Glu73 interaction may increase structural stability in hydrophobic environments. The interface between chains A and A2 and between chains A and B4 (which was the same as that between chains A4 and B) involves interactions between loop regions [ Fig. 5 (B), 5(F)]. These interactions are formed by hydrophilic residues in loop b18-19 (Lys266 and Asn269) in the interface between chains A and A2, and in loops b8-9 (Pro136), b10-11 (Thr159 and Ala160), and b18-19 (Val268 and Asn269) in chains A and B4 (A4-B). These loops may play a key role in establishing protein-protein interactions and stabilizing protein complexes. However, the b-strands are too far away to be in contact these protomer interfaces.
The interface between chains A and A4 is formed from b-strands 9-11 and has a buried surface area of 37.7 Å 2 [ Fig. 5(C) , Table II ). The interface also includes two acyl chains from lipid molecules that form CH/p interactions with the aromatic amino acids Tyr153 at b10 and Phe169 at b11, emphasizing the importance of protein-lipid interactions in the dimerization and higher-state oligomerization of hVDAC1. The final interface is between chains B2 and B3. However, the buried surface area of this interface (229.6 Å 2 ) indicates that there are no interactions between the two chains. The dimer conformation of the crystal in space group P22 1 2 1 is orientated anti-parallel. The interaction is formed by strands b7-10 (Arg120, Glu121, His122, Ile123, Leu125, Leu142, Leu144, Tyr153, and Met155) and strands b12-15 (Phe178, Ile194, Gln196, Val206, Leu208, Trp210, Ser215, Asn216, Thr217, and Phe219), and it includes one acyl chain [ Fig. 2(A), 2(B) ]. The packing of this anti-parallel dimer is different from that of the crystallographicimposed anti-parallel dimer of mVDAC1. 13, 20 Many studies have addressed the relationship between VDAC oligomerization and the induction of apoptosis, in which it is proposed that VDAC1s oligomerize to form a large pore to allow the passage of folded proteins such as cytochrome c upon the induction of apoptosis. 18, [32] [33] [34] [35] [36] In this process, the Nterminal domain of VDAC1 moves from the internal intra-molecular pore to the inter-molecular space of the newly formed large pore. 31, 35, 37 In our heptameric structure, however, no space created by a change in the N-terminal conformation was found through which cytochrome c could potentially pass (Fig. 5) . Therefore, it was difficult to determine the pathway of cytochrome c transport during apoptosis in our heptameric structure. Since the crystal used to determine our heptameric structure was obtained under conditions of high hVDAC1 protein concentration, the heptamer model obtained may reflect the state of the stabilized oligomer or the state before transition to the structure capable of transporting cytochrome c during apoptosis. Experiments using mutations at the heptamer interaction sites are warranted to further examine the oligomeric state at the cellular level.
Conclusion
Here, we present two crystal structures of hVDAC1 produced by using an E. coli cell-free synthesis system. We used the crystal structures to examine the interfaces between protomers and the higher oligomer interaction states of hVDAC1. A structural study suggested that hVDAC1 oligomerization involves several different interactions, such as hydrophobic interactions between b-strands, hydrophilic interactions between loop regions and one of the b-strands, and protein-lipid interactions. It is possible that VDACs interact with other proteins via these interfaces. hVDAC1 is a potentially useful target for pharmaceutical research because VDACs are key proteins in mitochondria-mediated apoptosis. 7 Indeed, previous studies have suggested that homo-or heterooligomers of VDAC with apoptosis-regulating proteins in the Bcl-2 family form pores through which apoptotic proteins in the intermembrane space are released into the cytoplasm. 7 Further studies are needed to examine the complexes formed between VDAC1, VDAC2, VDAC3, and these other proteins.
Materials and Methods
Construction of plasmids
The human VDAC1 gene (GenBank accession number, BC008482) was attached by overlap PCR to sequences encoding a modified histidine (N11, MKDHLIHNHH-KHEHAHAEH) affinity tag, a small ubiquitin related modifier (SUMO) fusion tag, and an additional His tagged sequence (-MRGSHHHHHHGS-) at the Nterminus, and then subcloned into the plasmid pCR2.1-TOPO. 38 When this additional His-tagged sequence was not included, SUMO protease could not digest the SUMO protease cleavage site (data not shown), probably because the N-terminal a-helical domain existed inside the hVDAC1 b-barrel structure, which made it difficult for SUMO protease to access. Therefore, an additional His-tagged sequence was added from the mVDAC1 construction (PDB ID: 3EMN). 13 Furthermore, addition of a hydrophilic polyhistidine region at the N-terminus likely increased the solubility of the hVDAC1 protein, which would have facilitated correct protein folding.
Cell-free protein synthesis and purification
The cell-free synthesis reaction was performed as described previously 39, 40 with some modifications.
Each 9-mL aliquot of reaction mixture included 1.0% digitonin (Wako pure chemicals Inc., Japan) and 6.67 mg/mL egg yolk phosphatidylcholine (Avanti Polar Lipids, Inc., USA). The reaction mixture was separated from the feeding solution by using dialysis membrane tubing with a 15-KDa cut-off (Spectrum Chemical Mfg. Corp., USA). The dialysis unit was incubated for 6 h at 308C. The reaction mixture was ultracentrifuged at 100,000g for 30 min at 48C. The resulting supernatant was collected as the solubilized hVDAC1 protein sample. The hVDAC1 protein was affinity purified on Ni-NTA Superflow resin (Qiagen) equilibrated with Buffer A (20 mM Tris-HCl [pH 8.0], 150 mM NaCl, and 0.1% lauryldimethylamine oxide), washed 10 times with 1.0 ml column volumes of 15 mM imidazole in Buffer A, and eluted with 400 mM imidazole in the same buffer. The N11 affinity and SUMO fusion tag was cleaved off by incubation overnight at 48C with SUMO specific protease (final concentration, 50 mg/mL), then the cleaved tag and the protease were removed by using a HiTrap Q anion exchange column pre-equilibrated in 20 mM Tris-HCl (pH 8.0), 50 mM NaCl, 0.1% lauryldimethylamine oxide, and 1 mM dithiothreitol. The flowthrough fraction was collected and concentrated by using a 30-KDa molecular weight cut-off Amicon Ultra filter unit (Merck Millipore Corp., Germany) then applied to a Superdex 200 10/300 column (GE Healthcare, USA) in Buffer A and 1 mM dithiothreitol. The fraction corresponding to the peak observed on size-exclusion chromatography was collected, concentrated again, and then used in the crystallization experiment. The final yield of hVDAC1 was 1.0 mg from 9.0 mL of the cell-free synthesis reaction mixture, as deduced by measuring absorbance at 280 nm.
Crystallization of hVDAC1 by using a Bicelle method Bicelles were prepared as described previously. 41 Purified hVDAC1 at a concentration of 15 mg/mL was mixed at a 4:1 protein/bicelle ratio with a 35% 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)/ 3-[(3-Cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate (CHAPSO) (2.8:1) bicellar solution, resulting in 12 mg/mL mVDAC1 in 7% bicelles.
Two types of crystals were obtained. Crystals in space group P22 1 2 1 were grown at 208C in 36% PEG300, 0.1 M MES (pH 6.5), and 0.1 M NaCl by using the sitting drop vapor diffusion method. Crystals in space group C222 were grown in 45% PEG300, 0.1 M HEPES (pH 7.0), 0.15 M NaCl, and 5 to 11 mM spermidine at 208C. Both types of crystal were flash frozen in liquid nitrogen.
Data collection, structure determination, and refinement
Diffraction data for two crystals in space group P22 1 2 1 and one crystal in space group C222 were collected with the BL32XU beamline of the SPring-8 synchrotron. 42 In addition, diffraction data for one crystal in space group C222 were collected with the X06SA beamline of the Swiss Light Source synchrotron. The diffraction data were processed with the XDS program package 43 and scaling the data with XSCALE (part of the XDS package), and the structure was solved by molecular replacement by using the Phaser program 44 in the Phenix software suite 45 with mVDAC1 (PDB ID: 3EMN) 13 as the search model. Refinement was conducted by using the Phenix 45 and REFMAC5 46 software suite, and the structure was manually rebuilt with the Coot program. 47 Data collection and refinement statistics are presented in Table I .
Electrophysiological monitoring in an artificial planar lipid bilayer
The electrophysiological properties of hVDAC1 were examined by using an Ionovation Compact instrument (Ionovation) and the painting method previously reported. 28 In short, an artificial planar lipid bilayer was formed on an aperture of diameter approximately 50 mm made in a 25-mm thick sheet of Teflon foil placed between cis-and trans-chambers filled with buffer (250 mM KCl, 2 mM CaCl 2 , 10 mM MOPS-Tris [pH 7.0]). The chambers were then connected to an amplifier via Ag/AgCl electrodes with 1 M KCl salt bridges. Bilayer formation was induced by addition to the trans-chamber (ground electrode) of 5 mg/mL Ionovation Bilayer-Lipid II, POPE/POPC 8:2 (Ionovation), which was dissolved in n-decane, and bilayer formation was monitored optically by using a CCD camera. In addition, the Ionovation Compact instrument can be used to monitor the change in capacitance in real-time, which we used as an indicator of proper membrane formation; a capacitance greater than 50 pF was considered to represent proper lipid bilayer formation. After bilayer formation, hVDAC1 protein was added to the cis-chamber (signal electrode). Currents were acquired at a sampling frequency of 10 kHz after the signal was passed through a low-pass filter at 3 kHz and digitized by using an EPC 10 Patch Clamp Amplifier and the Patchmaster software (HEKA). Electrophysiological properties were examined under constant voltages between 250 and 150 mV. Conductance was calculated by using the following equation: conductance (G) 5 current (I)/ voltage (V).
